期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状旁腺激素的不同检测方法及其在肾性骨病诊断中的价值 被引量：12

原文传递
导出
摘要 甲状旁腺激素（PTH）作为一种尿毒症毒素。日益引起人们关注。它可以引起多种器官损伤。如肾性骨病、心脏肥大、软组织钙化等。一直以来，PTH检测是临床上诊断、监测肾性骨病的主要手段。但近来有研究报道，维持性血透患者的PTH值不能正确判断骨转运状态。甚至iPTH〉500pg／ml的患者骨活检也有显示低转运性骨病的可能。那么。PTH水平是否能够反映骨病状态呢？还是PTH检测方法不能反映真实的PTH值呢？为此我们回顾一下目前的进展。
作者 郭云珊 袁伟杰 张国兆
机构地区 第二军医大学附属长海医院肾内科
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2006年第3期187-190,共4页 Chinese Journal of Nephrology
关键词 甲状旁腺激素 肾性骨病 临床上诊断 TH检测 维持性血透患者 价值 尿毒症毒素 软组织钙化 PTH 器官损伤
分类号 R692.5 [医药卫生—泌尿科学] R541.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献30

  • 1Jüppner H,Gardella TJ,Brown EM,et al.Parathyroid hormone,and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development.In:Degroot LJ,Jameson JL,eds.Endocrinology.4th ed.Philatelphia:WB Saunders,2001.969-998.
  • 2Samra AB,Jüppner H,Force T,et al.Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells:A single receptor stimulates intracellular accumulation of both camp and inositol triphosphates and increase intracellular free calcium.Proc Natl Acad Sci USA ,1992,89:2732-2736.
  • 3John MR,Arai M,Rubin DA,et al.Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues.Endocrinology,2002,143 :1047-1057.
  • 4Dobolyi A,Ueda H,Uchida H,et al.Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39residues in nociception.Proc Natl Acad Sci USA,2002,99:1651-1656.
  • 5Hoare SR,Rubin DA,Jüppner H,et al.Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors:comparion of PTH,PTH-related protein,and tuberoinfundibular peptide of 39 residues.Endocrinology,2000,141:3080-3086.
  • 6Nguyen-Yamamoto L,Rousseau L,Brossard JH,et al.Synthetic carboxyl-terminal fragments of parathyroid hormone (PT H)decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.Endocrinology,2001,42:1386-1392.
  • 7Slatopolsky E,Finch J,Clay P,et al.A novel machanism for skeletal resistance in uremia.Kidney Int,2000,58:753-761.
  • 8许多荣,余学清,方荸荠.甲状旁腺激素在体外对破骨细胞分化及骨重吸收能力的影响[J].中华肾脏病杂志,2005,21(4):186-190. 被引量：15
  • 9Faugere MC,Geng Z,Mawad H,et al.Improved assessment of bone turnover by the PTH-(1-84)/largeC-PTH fragments ratio in ESRD patients.Kidney Int,2001,60:1460-1468.
  • 10Andress DL,Norris KC,Coburn JW,et al.Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.N Engl J Med,1989,321:274-279.

二级参考文献14

  • 1Fong AM, Erickson HP, Zachariah JP, et al. Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation. J Biol Chem, 2000,75: 3781-3786.
  • 2Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the members of the tumor necrosis factor receptor and ligand fanilies. Endocr Res, 1999,20: 345-357.
  • 3Duorong Xu,Zhenqi Shi,Xu Feng,et al. Development of a chimacric receptor approach to study signaling by tumour necrosis factor family members. Biochem J, 2004,383:219-225.
  • 4Wei L, Duorong X, Hongmei Y, et al. Functional identification of three RANK cytoplasmic motif mediating osteoclast differentiation and function. J Biol Chem, 2004,279:54759-54769.
  • 5Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteogenesisinhibitory factor and is identical to TRANCE/RANKL.Proc Natl Acad Sci UAS, 1998,95:3597-3602.
  • 6Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the members of the tumor necrosis factor receptor and ligand families. Endocr Res, 1999,20: 345-357.
  • 7Hofbauer L, Khosla S, Dunstan C, et al. The roles of osteoprotegerin and osteoprogerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res,2000, 15:2-12.
  • 8Shi W, Michael WH, Steven L, et al. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-κB and Mitogen-activated protein kinase signaling. J Biol Chem,2002,277: 6622-6630.
  • 9Simonet W, Lacey D, Dunstan C, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell, 1997,89: 309-319.
  • 10Schiller P, Ippolito G, Roos B, et al. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment.J Bone Miner Res, 1999,14: 1504-1512.

共引文献14

同被引文献147

引证文献12

二级引证文献60

中华肾脏病杂志
2006年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部